Cited by 9Polyomavirus and related diseasesinterferon and immune responsesImmunotherapy and Immune Responses

Merkel cell polyomavirus protein ALTO modulates TBK1 activity to support persistent infection

Open access
Wang, Ranran, Senay, Taylor E., Luo, Tiana T., Liu, Wei, Regan, James M., Salisbury, Nicholas J. H., Galloway, Denise A., You, Jianxin·2024·PLOS Pathogens

Published version of a preprint

Abstract

While Merkel cell polyomavirus (MCPyV or MCV) is an abundant virus frequently shed from healthy skin, it is one of the most lethal tumor viruses in immunocompromised individuals, highlighting the crucial role of host immunity in controlling MCPyV oncogenic potential. Despite its prevalence, very little is known about how MCPyV interfaces with the host immune response to maintain asymptomatic persistent infection and how inadequate control of MCPyV infection triggers MCC tumorigenesis. In this study, we discovered that the MCPyV protein, known as the Alternative Large Tumor Open Reading Frame (ALTO), also referred to as middle T, effectively primes and activates the STING signaling pathway. It recruits Src kinase into the complex of STING downstream kinase TBK1 to trigger its autophosphorylation, which ultimately activates the subsequent antiviral immune response. Combining single-cell analysis with both loss- and gain-of-function studies of MCPyV infection, we demonstrated that the activity of ALTO leads to a decrease in MCPyV replication. Thus, we have identified ALTO as a crucial viral factor that modulates the STING-TBK1 pathway, creating a negative feedback loop that limits viral infection and maintains a delicate balance with the host immune system. Our study reveals a novel mechanism by which a tumorigenic virus-encoded protein can link Src function in cell proliferation to the activation of innate immune signaling, thereby controlling viral spread, and sustaining persistent infection. Our previous findings suggest that STING also functions as a tumor suppressor in MCPyV-driven oncogenesis. This research provides a foundation for investigating how disruptions in the finely tuned virus-host balance, maintained by STING, could alter the fate of MCPyV infection, potentially encouraging malignancy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1012170

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Wang, R., Senay, T. E., Luo, T. T., Liu, W., Regan, J. M., Salisbury, N. J. H., Galloway, D. A., & You, J.
Affiliations
  • University of Pennsylvania (US)
  • Fred Hutch Cancer Center (US)
Corresponding author
You, Jianxin
Venue
PLOS Pathogens
Published
2024-07-29
Volume
20
Issue
7
Pages
e1012170
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W4401070609
Cited by
9
References
2
Citations by year
2026: 5 · 2025: 4
FWCI
1.54
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (R01CA187718, R21CA267803, R01CA284690)
  • National Cancer Institute (P50-CA174523, P01CA281867 (Project 3))
Topics
  • Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
Merkel cell polyomavirus, alto, middle T antigen, STING signaling, TBK1, Src kinase, viral persistence, antiviral innate immunity, viral replication, tumor suppressor, host-virus interaction
MeSH terms
STING Protein, Animals, Humans, Membrane Proteins, Skin Neoplasms, Tumor Virus Infections, Viral Proteins, Virus Replication, Carcinoma, Merkel Cell, Signal Transduction, Protein Serine-Threonine Kinases, Polyomavirus Infections, Merkel cell polyomavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review